GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...
LBT-3627 is under development for the treatment of Parkinson's disease. The drug candidate is administered through oral route. It is developed based on hybridtide scaffold technology. It acts by ...
A new study suggests cannabidiol (CBD) could be a game-changer in fighting gum disease, showing significant antibacterial and antibiofilm effects against harmful oral bacteria. Researchers from Brazil ...